COLY Insider Trading Activity and SEC Form 4 Filings
COLY insider trading summary
No open-market insider purchases or sales of Coley Pharmaceutical Group, Inc. (COLY) have been reported on SEC Form 4 in the past 12 months.
Latest COLY insider buys and sells
| Date | Insider | Role | Type | Value |
|---|---|---|---|---|
| Dec 6, 2007 | Manfred E Karobath | Director | Sell | $214K (27,000 @ $7.93) |
| Aug 29, 2007 | Arthur M Krieg | SVP, R & D, Chief Scien. Off. | Sell | $40K (21,070 @ $1.89) |
| May 11, 2007 | James E Thomas | Director | Buy | $520K (60,000 @ $8.66) |
| May 10, 2007 | James E Thomas | Director | Buy | $868K (100,000 @ $8.68) |
| May 8, 2007 | Manfred E Karobath | Director | Buy | $63K (7,000 @ $8.98) |
| May 8, 2007 | Manfred E Karobath | Director | Buy | $45K (5,000 @ $9.01) |
| May 8, 2007 | Manfred E Karobath | Director | Buy | $46K (5,000 @ $9.22) |
| May 8, 2007 | Manfred E Karobath | Director | Buy | $45K (5,000 @ $8.99) |
| May 8, 2007 | Manfred E Karobath | Director | Buy | $45K (5,000 @ $9.00) |
| Dec 7, 2006 | Arthur M Krieg | SVP, R & D, Chief Scien. Off. | Sell | $41K (18,122 @ $2.24) |
Source: SEC Form 4 filings. Open-market purchases (code P) and sales (code S) only; option exercises, grants and gifts are excluded.